Jules A. Musing - Net Worth and Insider Trading

Jules A. Musing Net Worth

The estimated net worth of Jules A. Musing is at least $150 dollars as of 2024-11-13. Jules A. Musing is the Director of TherapeuticsMD Inc and owns about 100 shares of TherapeuticsMD Inc (TXMD) stock worth over $150. Details can be seen in Jules A. Musing's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jules A. Musing has not made any transactions after 2019-02-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jules A. Musing

To

Jules A. Musing Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jules A. Musing owns 2 companies in total, including TherapeuticsMD Inc (TXMD) , and iBio Inc (IBIO) .

Click here to see the complete history of Jules A. Musing’s form 4 insider trades.

Insider Ownership Summary of Jules A. Musing

Ticker Comapny Transaction Date Type of Owner
TXMD TherapeuticsMD Inc 2022-08-18 director
IBIO iBio Inc 2011-06-20 director

Jules A. Musing Latest Holdings Summary

Jules A. Musing currently owns a total of 1 stock. Jules A. Musing owns 100 shares of TherapeuticsMD Inc (TXMD) as of February 27, 2019, with a value of $150.

Latest Holdings of Jules A. Musing

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TXMD TherapeuticsMD Inc 2019-02-27 100 1.50 150

Holding Weightings of Jules A. Musing


Jules A. Musing Form 4 Trading Tracker

According to the SEC Form 4 filings, Jules A. Musing has made a total of 0 transactions in TherapeuticsMD Inc (TXMD) over the past 5 years. The most-recent trade in TherapeuticsMD Inc is the sale of 348 shares on February 27, 2019, which brought Jules A. Musing around $100,920.

Insider Trading History of Jules A. Musing

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jules A. Musing Trading Performance

GuruFocus tracks the stock performance after each of Jules A. Musing's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jules A. Musing is 112.67%. GuruFocus also compares Jules A. Musing's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jules A. Musing within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jules A. Musing's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jules A. Musing

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 28.51 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 25.98 LIMIT LIMIT LIMIT LIMIT LIMIT

Jules A. Musing Ownership Network

Ownership Network List of Jules A. Musing

No Data

Ownership Network Relation of Jules A. Musing

Insider Network Chart

Jules A. Musing Owned Company Details

What does TherapeuticsMD Inc do?

Who are the key executives at TherapeuticsMD Inc?

Jules A. Musing is the director of TherapeuticsMD Inc. Other key executives at TherapeuticsMD Inc include General Counsel Marlan D Walker , Principal Financial Officer Joseph Ziegler , and CAO and VP of Finance Michael C Donegan .

TherapeuticsMD Inc (TXMD) Insider Trades Summary

Over the past 18 months, Jules A. Musing made no insider transaction in TherapeuticsMD Inc (TXMD). Other recent insider transactions involving TherapeuticsMD Inc (TXMD) include a net purchase of 5,294 shares made by Collins Cooper C. , and a net sale of 19,050 shares made by Marlan D Walker .

In summary, during the past 3 months, insiders sold 0 shares of TherapeuticsMD Inc (TXMD) in total and bought 5,294 shares, with a net purchase of 5,294 shares. During the past 18 months, 19,050 shares of TherapeuticsMD Inc (TXMD) were sold and 5,294 shares were bought by its insiders, resulting in a net sale of 13,756 shares.

TherapeuticsMD Inc (TXMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

TherapeuticsMD Inc Insider Transactions

No Available Data

Jules A. Musing Mailing Address

Above is the net worth, insider trading, and ownership report for Jules A. Musing. You might contact Jules A. Musing via mailing address: 9 Innovation Way, Suite 100, Newark De 19711.